Steven Reichling, Chief Financial Officer at Accelerate Diagnostics, Inc (AXDX), sold 78,658 shares at $9.50 ($747K) on 2020-11-09, disclosed to the SEC on 2020-11-12.
Open-market sale of $747k AXDX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.50 | 39,329 | $374K | 50.0% |
| 2 | $9.50 | 39,329 | $374K | 50.0% |
| Total | $9.50 avg | 78,658 | $747K | 100% |
| Filing → |
| AXDX | SELL | 2023-02-15 | $3K | — | Filing → |
| AXDX | SELL | 2023-01-17 | $3K | — | Filing → |
| AXDX | BUY | 2022-08-22 | $7K | — | Filing → |